NasdaqGS:VIRBiotechs
Assessing Vir Biotechnology (VIR) Valuation After Recent Share Price Momentum
What recent performance says about Vir Biotechnology (VIR)
Vir Biotechnology (VIR) has attracted attention after a recent 2.6% daily gain, capping a month in which the stock returned about 26.7% and roughly 38.4% over the past 3 months.
See our latest analysis for Vir Biotechnology.
That recent surge sits within a stronger trend, with a 30 day share price return of 26.7%, a year to date share price return of 79.1%, and a 1 year total shareholder return of 74.4%. However, the 3 and 5 year...